Arne Skerra is Full Professor at the Technische Universität München, where he heads the Institute of Biological Chemistry since 1998. He holds a Diploma degree in chemistry from the Technische Universität Darmstadt and a PhD in Biochemistry from the Ludwig-Maximilians-Universität München. After post-doctoral studies at the MRC Laboratory of Molecular Biology in Cambridge, UK, and a group leader position at the Max-Planck-Institute for Biophysics

Claus Schalper has a solid background in financial management, combined with practical experience in fund raising and driving business growth. Mr. Schalper began his career with Arthur Andersen in the Audit and Corporate Finance Department. Subsequently, he joined a start-up company in the area of healthcare IT software as general partner. Following the trade-sale of the company, Mr. Schalper served as an advisor to venture capitalists specializi

Uli Binder studied protein biochemistry, microbiology, and also business administration and he received his Master's degree in molecular biotechnology from the Technische Universität München in 2006. He worked on his PhD thesis in the field of protein engineering in the laboratory of Prof. Skerra. He participated in setting up the Gene Technology Visitors' Lab at the Deutsche Museum München and acted for several years as course instructor for var